Untargeted Metabolomics in the Discovery of Novel Biomarkers and Therapeutic Targets for Atherosclerotic Cardiovascular Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-4063|18|3|166-175

ISSN： 1871-529X

Source： Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol.18, Iss.3, 2018-12, pp. : 166-175

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases

By  

Current Drug Targets - Cardiovascular & Hematological Disorders, Vol. 5, Iss. 6, 2005-12 ,pp. : 533-540

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Systemic Cardiovascular Disease Biomarkers

By  

Current Molecular Medicine, Vol. 10, Iss. 2, 2010-03 ,pp. : 180-205

Bentham Science Publishers

Access to resources Recommend Favorite

Integrins as Therapeutic Targets for Respiratory Diseases

By  

Current Molecular Medicine, Vol. 15, Iss. 8, 2015-09 ,pp. : 714-734

Bentham Science Publishers

Access to resources Recommend Favorite

Thioredoxin-1 is a Novel and Attractive Therapeutic Approach for Various Diseases Including Cardiovascular Disorders

By  

Cardiovascular & Haematological Disorders - Drug Targets(Formerly Current Drug Targets - Cardiovascular & Hematological Disorders), Vol. 8, Iss. 4, 2008-12 ,pp. : 293-296

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics in the Discovery of New Therapeutic Targets for Psychiatric Disease

By  

Current Molecular Medicine, Vol. 3, Iss. 5, 2003-08 ,pp. : 447-458

Bentham Science Publishers

Access to resources Recommend Favorite